3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Renal Cell
10
Kidney Neoplasms
5
Neoplasms
4
Gastrointestinal Stromal Tumors
4
Breast Neoplasms
2
Thyroid Neoplasms
1
Somatostatinoma
1
Solid Tumors
1
Refractory Solid Tumors
1
Neoplasm Metastasis
1
Glioma
1
Gastrointestinal Neoplasms
1
Fatigue
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Adenoma, Islet Cell
1
Interventions
Surveys and Questionnaires
9
Standard of Care
5
Endoscopic Mucosal Resection
5
Educational Status
5
Blood Specimen Collection
5
Diet Therapy
3
Referral and Consultation
2
Quality of Life
2
Practice Guidelines as Topic
2
Palliative Care
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Control Groups
2
Aprepitant
2
Acceptance and Commitment Therapy
2
vandetanib
1
fosaprepitant
1
dolasetron
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Weights and Measures
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surgical Instruments
1
Sunitinib
1
Sorafenib
1
Sampling Studies
1
Restraint, Physical
1
Remote Patient Monitoring
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Gastrointestinal Neoplasms
×
Sunitinib
×
Clear all
NCT02013089
2016-08-30
GITIC
Sun Yat-sen University
Phase NA
Unknown
50 enrolled